Comparison of breast cancer surrogate subtyping using a closed-system RT-qPCR breast cancer assay and immunohistochemistry on 100 core needle biopsies with matching surgical specimens

BACKGROUND: Routine clinical management of breast cancer (BC) currently depends on surrogate subtypes according to estrogen- (ER) and progesterone (PR) receptor, Ki-67, and HER2-status. However, there has been growing demand for reduced immunohistochemistry (IHC) turnaround times. The Xpert® Breast...

Descripción completa

Detalles Bibliográficos
Autores principales: Janeva, Slavica, Parris, Toshima Z., Nasic, Salmir, De Lara, Shahin, Larsson, Karolina, Audisio, Riccardo A., Bagge, Roger Olofsson, Kovács, Anikó
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059293/
https://www.ncbi.nlm.nih.gov/pubmed/33879115
http://dx.doi.org/10.1186/s12885-021-08171-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059293/
https://www.ncbi.nlm.nih.gov/pubmed/33879115
http://dx.doi.org/10.1186/s12885-021-08171-2

Ejemplares similares